Explore more publications!

Technology Review Mississippi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Mississippi.

Press releases published on January 23, 2026

Litchfield Hills Research: Society Pass Incorporated’s (Nasdaq: SOPA) Total Asset Value Implies Valuation of 1,300% of Current Market Capitalization
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
GPGI, Inc. Completes Rebrand and Starts Trading as GPGI on NYSE
OpenTitan Introduces New Membership Tiers and Deliverables to Accelerate Deployment
NextCure Provides Business Update 
Shoals Technologies Group, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
デイワン、ヌルミヤルヴィにおける初期段階のデータセンター計画で、フィンランドのプラットフォームを拡大
DayOne Memajukan Platform Finland dengan Rancangan Awal Pusat Data di Nurmijärvi
DayOne Memajukan Platform Finlandia dengan Rencana Pusat Data Tahap Awal di Nurmijärvi
DayOne, 누르미얘르비 초기 단계 데이터센터 계획으로 핀란드 플랫폼 확대
DayOne เดินหน้าพัฒนาแพลตฟอร์มในฟินแลนด์ ด้วยแผนการสร้างศูนย์ข้อมูลระยะเริ่มต้นใน Nurmijärvi
BlissBot Announces the Global Launch of StarHealing: A Quantum-Inspired Program in Autism Intervention
Ourbit Accelerates Cross-Market Strategy with Commodities, Tokenised Stocks and Big Rewards
Quantexa Claims Accelerator Now Available on Guidewire Marketplace, Bringing Real-Time Decision Intelligence to Insurance Claims
WOW Exchange Surpasses 80,000 Users in First 5 Days — Launches Innovative Campaign Feature Set to Transform InfoFi Engagement
Steph McGovern launches new Teesside University scholarship to support women in engineering
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions